20-HETE Mimetics or Inhibitors in the Treatment of Cancer Patients with Sepsis and Septic Shock

Journal Title: International Journal of Cancer Studies & Research (IJCR) - Year 2013, Vol 2, Issue 1

Abstract

Patients with a variety of malignancies have a greater tendency to acquire infections than patients with non-malignant disorders. Sepsis and septic shock are common complications in patients with cancer. As the most common causes of morbidity and mortality in intensive care units worldwide, the societal and economic costs of cancer, sepsis, and septic shock are staggering. The molecular pathophysiology of cancer, sepsis, and septic shock remains controversial despite decades of study. 20Hydroxyeicosatetraenoic acid (20-HETE), a ω-hydroxylation product of arachidonic acid that is produced by cytochrome P450 (CYP) enzymes, mainly by CYP4A and CYP4F isoforms, has been implicated in the regulation of protooncogenic, mitogenic, and angiogenic responses both in vitro and in vivo as well as inflammation that can support tumor progression. Therefore, selective 20-HETE inhibitors has been suggested to be a new class of compounds with antitumor and antiangiogenic activity. On the other hand, studies from our laboratory and others have provided substantial evidence that administration of a synthetic analog of 20-HETE, N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine, a 20-HETE mimetic, prevents vascular hyporeactivity, hypotension, tachycardia, inflammation, and mortality presumably due to increased CYP4A1 expression and formation of 20-HETE associated with decreased vasodilatory and proinflammatory mediator production in a rodent model of septic shock. This review will focus on the rationale for the use of 20-HETE mimetics or inhibitors for the treatment of cancer patients with sepsis and septic shock

Authors and Affiliations

Tunctan B

Keywords

Related Articles

Store-Operated Calcium Channel and Cancer

The increase of intracellular Ca2+ concentration is an important mechanism that regulates a variety of physiological processes ranging from exocytosis to gene regulation and cell proliferation [1]. Calcium release from...

Frequency and Determining Factors of Empiric Chemotherapy Dose Reduction in Patients with Non-Small Cell Lung Cancer

Objectives: To determine the frequency and key factors regarding empiric chemotherapy dose reductions (ECDR) in nonsmall cell lung cancer (NSCLC) patients. Methods: This retrospective study involved the chart review of...

The Influence of Lifestyle Risk Factors on the Occurrence of Gynecological Cancers: A Review of the Evidence and Opportunities for Prevention and Management

Over one million gynecologic cancers have been diagnosed in women worldwide. The five main types of gynecologic cancer are: uterine, ovarian, cervical, vulvar and vaginal. This review describes the current evidence regar...

Incidentally Detected Spindle Cell Tumor on F-18 FDG PET/CT for Staging of Lung Cancer

A 77-year-old male visited the hospital due to dyspnea, cough and sputum production, and a lung mass on chest radiography. F-18 fluorodeoxyglucose (FDG) positron emission tomography/ computed tomography (PET/CT) demonstr...

Are there any Dermoscopic Signs of Primary Cutaneous Follicular Center B-cell Lymphoma?

Cutaneous follicular center B-cell lymphoma is an indolent tumor that arise on head or neck. Histology by immunotyping with monoclonal antibodies in frozen or paraffin - embedded tissue is necessary for diagnosis. The tu...

Download PDF file
  • EP ID EP197890
  • DOI 10.19070/2167-9118- 130001
  • Views 110
  • Downloads 0

How To Cite

Tunctan B (2013). 20-HETE Mimetics or Inhibitors in the Treatment of Cancer Patients with Sepsis and Septic Shock. International Journal of Cancer Studies & Research (IJCR), 2(1), 1-12. https://europub.co.uk/articles/-A-197890